Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 12;15(6):e40299.
doi: 10.7759/cureus.40299. eCollection 2023 Jun.

Ocular Manifestations of Inflammatory Bowel Disease

Affiliations
Review

Ocular Manifestations of Inflammatory Bowel Disease

Erik Licona Vera et al. Cureus. .

Abstract

Inflammatory bowel disease (IBD) is a chronic disease connected to the immune system, with a predilection for the gastrointestinal tract. However, a large proportion of the patients have extraintestinal manifestations (EIM), and the ocular system is affected in some patients. The clinical presentation of ocular pathology is broad, ranging from asymptomatic cases to blindness, leading to high morbidity. Ocular complications can be primary and, in general, are associated with episodes of acute flare-ups that subside with immunological management of the digestive disease. Secondary complications arise from the primary ones and as adverse effects of immunological treatment. In addition, on many occasions, the ocular manifestation may appear prior to the presentation of digestive symptoms. The presence of a multidisciplinary team that includes a gastroenterologist and an ophthalmologist is important in order to achieve early diagnosis of ocular complications, thereby preventing, treating, and avoiding unfavorable and irreversible long-term ocular sequelae.

Keywords: crohn’s disease; episcleritis; inflammatory bowel disease; ocular; scleritis and uveitis; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. The epidemiology and risk factors of inflammatory bowel disease. Ye Y, Pang Z, Chen W, Ju S, Zhou C. https://pubmed.ncbi.nlm.nih.gov/26885239/ Int J Clin Exp Med. 2015;8:22529–22542. - PMC - PubMed
    1. Ophthalmic manifestations in patients with inflammatory bowel disease: a review. Troncoso LL, Biancardi AL, de Moraes HV Jr, Zaltman C. World J Gastroenterol. 2017;23:5836–5848. - PMC - PubMed
    1. Ulcerative colitis. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Lancet. 2017;389:1756–1770. - PMC - PubMed
    1. The global burden of IBD: from 2015 to 2025. Kaplan GG. Nat Rev Gastroenterol Hepatol. 2015;12:720–727. - PubMed
    1. Fenoglio-Preiser CM. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008. Gastrointestinal Pathology: An Atlas and Text.

LinkOut - more resources